Chuong Pham-Huy
Chuong Pham-Huy has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Hua He
Department of Analytical Chemistry, China Pharmaceutical University, Nanjing 210009, China
2 shared publications - Catherine Foulon
Univ. Lille, CHU Lille, ULR 7365-GRITA, F-59000 Lille, France
1 shared publication - Clémence Martin
Department of Respiratory Medicine, APHP Centre, Institut Cochin (UMR 1016), Assistance Publique—Hôpitaux de Paris, Cochin Hospital, Université Paris Cité, 75006 Paris, France
1 shared publication Deli Xiao
China Pharmaceutical University, Nanjing 210009, China
1 shared publication- Deli Xiao
Department of Analytical Chemistry, China Pharmaceutical University, Nanjing, China
1 shared publication - François Guyon
Service Commun des Laboratoires, Laboratoire de Marseille, 146 Traverse Charles Susini, Marseille 13388, France
1 shared publication
Latest Publications
- Open Access
- 30 September 2013
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-12
Carbon Nanotubes: Applications in Pharmacy and Medicine
Carbon nanotubes (CNTs) are allotropes of carbon, made of graphite and constructed in cylindrical tubes with nanometer in diameter and several millimeters in length. Their impressive structural, mechanical, and electronic properties are due to their small size and mass, their strong mechanical potency, and their high electrical and thermal conductivity. CNTs have been successfully applied in pharmacy and medicine due to their high surface area that is capable of adsorbing or conjugating with a wide variety of therapeutic and diagnostic agents (drugs, genes, vaccines, antibodies, biosensors, etc.). They have been first proven to be an excellent vehicle for drug delivery directly into cells without metabolism by the body. Then other applications of CNTs have been extensively performed not only for drug and gene therapies but also for tissue regeneration, biosensor diagnosis, enantiomer separation of chiral drugs, extraction and analysis of drugs and pollutants. Moreover, CNTs have been recently revealed as a promising antioxidant. This minireview focuses the applications of CNTs in all fields of pharmacy and medicine from therapeutics to analysis and diagnosis as cited above. It also examines the pharmacokinetics, metabolism and toxicity of different forms of CNTs and discusses the perspectives, the advantages and the obstacles of this promising bionanotechnology in the future.
- 30 September 2013
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-12
Open AccessCarbon Nanotubes: Applications in Pharmacy and Medicine
Carbon nanotubes (CNTs) are allotropes of carbon, made of graphite and constructed in cylindrical tubes with nanometer in diameter and several millimeters in length. Their impressive structural, mechanical, and electronic properties are due to their small size and mass, their strong mechanical potency, and their high electrical and thermal conductivity. CNTs have been successfully applied in pharmacy and medicine due to their high surface area that is capable of adsorbing or conjugating with a wide variety of therapeutic and diagnostic agents (drugs, genes, vaccines, antibodies, biosensors, etc.). They have been first proven to be an excellent vehicle for drug delivery directly into cells without metabolism by the body. Then other applications of CNTs have been extensively performed not only for drug and gene therapies but also for tissue regeneration, biosensor diagnosis, enantiomer separation of chiral drugs, extraction and analysis of drugs and pollutants. Moreover, CNTs have been recently revealed as a promising antioxidant. This minireview focuses the applications of CNTs in all fields of pharmacy and medicine from therapeutics to analysis and diagnosis as cited above. It also examines the pharmacokinetics, metabolism and toxicity of different forms of CNTs and discusses the perspectives, the advantages and the obstacles of this promising bionanotechnology in the future.
- 1 September 2012
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 12 (9) , 7271-7279
Adsorption Behavior of Pazufloxacin Mesilate on Amino-Functionalized Carbon Nanotubes
In this study, the interaction between amino-functionalized multi-walled carbon nanotubes (e-MWNTs) and antibacterial agents was investigated and the drug-loading ability of e-MWNTs was evaluated. The e-MWNTs were prepared and characterized, then were used as adsorbents for loading an antibacterial agent, pazufloxacin mesilate (PZFX). The adsorption behavior of PZFX on e-MWNTs in water was investigated. The results showed that e-MWNTs were able to form supramolecular complexes with PZFX and could be used as drug carriers with high drug-loading efficiency. Compared with pristine multi-walled carbon nanotubes (MWNTs), the adsorption efficiency of e-MWNTs was better. In kinetic studies, the pseudo-second-order model showed satisfactory fitting and good adsorption process. Langmuir model was successfully employed to describe the adsorption isotherms of PZFX on e-MWNTs and higher drug-loading ability were observed from e-MWNTs with smaller diameter. The adsorption process of e-MWNTs was sensitive to the pH and it was observed that the neutral pH gave the best adsorption. Low temperatures facilitated the adsorption process. In addition, the release process of PZFX from e-MWNTs occurred in two stages: a rapid release, then followed by a slow release, in which acidic solution favored the release process. In summary, our technique developed for the adsorption of PZFX on e-MWNTs is satisfactory.
- 1 September 2012
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 12 (9) , 7271-7279
Adsorption Behavior of Pazufloxacin Mesilate on Amino-Functionalized Carbon Nanotubes
In this study, the interaction between amino-functionalized multi-walled carbon nanotubes (e-MWNTs) and antibacterial agents was investigated and the drug-loading ability of e-MWNTs was evaluated. The e-MWNTs were prepared and characterized, then were used as adsorbents for loading an antibacterial agent, pazufloxacin mesilate (PZFX). The adsorption behavior of PZFX on e-MWNTs in water was investigated. The results showed that e-MWNTs were able to form supramolecular complexes with PZFX and could be used as drug carriers with high drug-loading efficiency. Compared with pristine multi-walled carbon nanotubes (MWNTs), the adsorption efficiency of e-MWNTs was better. In kinetic studies, the pseudo-second-order model showed satisfactory fitting and good adsorption process. Langmuir model was successfully employed to describe the adsorption isotherms of PZFX on e-MWNTs and higher drug-loading ability were observed from e-MWNTs with smaller diameter. The adsorption process of e-MWNTs was sensitive to the pH and it was observed that the neutral pH gave the best adsorption. Low temperatures facilitated the adsorption process. In addition, the release process of PZFX from e-MWNTs occurred in two stages: a rapid release, then followed by a slow release, in which acidic solution favored the release process. In summary, our technique developed for the adsorption of PZFX on e-MWNTs is satisfactory.
- 1 December 1999
- Published by Springer Nature in Chromatographia
- Vol. 50 (11-12) , 721-727
Rapid analysis of benzoylecgonine, cocaine, and cocaethylene in urine, serum, and saliva by isocratic high-performance liquid chromatography with diode-array detection
- 1 December 1999
- Published by Springer Nature in Chromatographia
- Vol. 50 (11-12) , 721-727
Rapid analysis of benzoylecgonine, cocaine, and cocaethylene in urine, serum, and saliva by isocratic high-performance liquid chromatography with diode-array detection
- 1 March 1995
- Published by Springer Nature in Archives of Toxicology
- Vol. 69 (5) , 346-349
In vitro metabolism of cyclosporin A with rabbit renal or hepatic microsomes: analysis by HPLC-FPIA and HPLC-MS
Cyclosporin A (CsA) is in vivo mainly metabolized by hepatic cytochrome P450 IIIA to more than 21 metabolites, the major ones known as: M1, M17 and M21. The aim of this work is to explore the in vitro metabolism of CsA after incubation, in the presence of NADPH, with renal or hepatic microsomes obtained from rabbits pretreated with rifampycin (enzyme inducer) or erythromycin (enzyme inhibitor). The presumed metabolites were separated by semi-preparative high-performance liquid chromatography (HPLC) and identified in each collected fraction by fluorescence polarization immunoassay (FPIA) (HPLC-FPIA) using a non-specific polyclonal antibody. They were also analyzed by HPLC-mass spectrometry (MS) using fast atom bombardment (HPLC-MS-FAB). Five collected fractions gave positive results with FPIA. The major metabolites found were M1, M17 and M21 after identification by HPLC-MS-FAB and comparison with three corresponding standard metabolites. The CsA biotransformation rates were calculated by the amount of unmetabolized CsA and were linear with time. These mean rates (Vm) for 12-min incubation by renal microsomes of rabbits treated with rifampicin or erythromycin or untreated (control) were 0.11, 0.02 and 0.04 nmol/min × mg microsomal protein, respectively. These rates were 15-, 37-, and 30-fold lower than those obtained with hepatic microsomes of rabbits treated identically. As CsA metabolites are less cytotoxic than the parent drug, this weak renal biotransformation of CsA after in vitro incubation should be one of the mechanisms of its in vivo nephrotoxicity.
- 1 March 1995
- Published by Springer Nature in Archives of Toxicology
- Vol. 69 (5) , 346-349
In vitro metabolism of cyclosporin A with rabbit renal or hepatic microsomes: analysis by HPLC-FPIA and HPLC-MS
Cyclosporin A (CsA) is in vivo mainly metabolized by hepatic cytochrome P450 IIIA to more than 21 metabolites, the major ones known as: M1, M17 and M21. The aim of this work is to explore the in vitro metabolism of CsA after incubation, in the presence of NADPH, with renal or hepatic microsomes obtained from rabbits pretreated with rifampycin (enzyme inducer) or erythromycin (enzyme inhibitor). The presumed metabolites were separated by semi-preparative high-performance liquid chromatography (HPLC) and identified in each collected fraction by fluorescence polarization immunoassay (FPIA) (HPLC-FPIA) using a non-specific polyclonal antibody. They were also analyzed by HPLC-mass spectrometry (MS) using fast atom bombardment (HPLC-MS-FAB). Five collected fractions gave positive results with FPIA. The major metabolites found were M1, M17 and M21 after identification by HPLC-MS-FAB and comparison with three corresponding standard metabolites. The CsA biotransformation rates were calculated by the amount of unmetabolized CsA and were linear with time. These mean rates (Vm) for 12-min incubation by renal microsomes of rabbits treated with rifampicin or erythromycin or untreated (control) were 0.11, 0.02 and 0.04 nmol/min × mg microsomal protein, respectively. These rates were 15-, 37-, and 30-fold lower than those obtained with hepatic microsomes of rabbits treated identically. As CsA metabolites are less cytotoxic than the parent drug, this weak renal biotransformation of CsA after in vitro incubation should be one of the mechanisms of its in vivo nephrotoxicity.